Antibody-Drug Conjugate Treatment Response Score (ADC TRS)
Multiple cancers for ADC therapy benefit
Key Facts
About Strata Oncology
Strata Oncology is a private, commercial-stage diagnostics company founded in 2016 and headquartered in Ann Arbor, Michigan. It has developed a proprietary precision oncology platform that generates multivariate biomarker scores, notably the Immunotherapy Response Score (IRS) and the Antibody-Drug Conjugate Treatment Response Score (ADC TRS), to predict patient benefit from specific cancer therapies. The company's model is based on providing diagnostic testing services and partnering with biopharma companies, positioning it at the intersection of AI-driven diagnostics and clinical decision support in oncology. Its growth is supported by recognized investors and a focus on expanding the clinical utility of its innovative biomarkers.
View full company profile